|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.71 USD | +0.22% |
|
+2.62% | -11.26% |
Company Valuation: Surgery Partners, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 4,694 | 3,370 | 4,015 | 2,676 | 1,985 | 1,777 | - | - |
| Change | - | -28.22% | 19.14% | -33.36% | -25.82% | -10.48% | - | - |
| Enterprise Value (EV) 1 | 7,243 | 5,709 | 6,594 | 5,776 | 5,447 | 5,310 | 5,364 | 5,583 |
| Change | - | -21.19% | 15.51% | -12.4% | -5.7% | -2.51% | 1.02% | 4.08% |
| P/E ratio | -47.7x | -47.2x | -355x | -15.9x | -25.3x | -94.9x | 104x | 44.4x |
| PBR | 3.55x | 1.28x | 2.03x | 1.5x | 1.17x | 1.07x | 1.2x | 1.15x |
| PEG | - | 1x | 4.2x | -0x | 0.5x | 1.2x | -1x | 0x |
| Capitalization / Revenue | 2.11x | 1.33x | 1.46x | 0.86x | 0.6x | 0.52x | 0.5x | 0.47x |
| EV / Revenue | 3.26x | 2.25x | 2.4x | 1.85x | 1.65x | 1.56x | 1.5x | 1.47x |
| EV / EBITDA | 21.3x | 15x | 15.1x | 11.4x | 10.4x | 9.99x | 9.34x | 9.29x |
| EV / EBIT | 32.4x | 23.1x | 21.8x | 16.2x | 15.6x | 13.7x | 12.2x | 12.7x |
| EV / FCF | -71.4x | -83.2x | 112x | 27.5x | 27.8x | 16.3x | 15.1x | 20x |
| FCF Yield | -1.4% | -1.2% | 0.89% | 3.63% | 3.59% | 6.14% | 6.61% | 5.01% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -1.12 | -0.59 | -0.09 | -1.33 | -0.61 | -0.1445 | 0.1322 | 0.3087 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 2,225 | 2,539 | 2,743 | 3,114 | 3,309 | 3,408 | 3,588 | 3,810 |
| EBITDA 1 | 339.6 | 380.2 | 438.1 | 508.2 | 526.2 | 531.6 | 574.3 | 600.8 |
| EBIT 1 | 223.4 | 247 | 302.3 | 355.6 | 350.2 | 388.6 | 438 | 440.3 |
| Net income 1 | -81.2 | -54.6 | -11.9 | -168.1 | -77.9 | -33.47 | 10.13 | 49.82 |
| Net Debt 1 | 2,549 | 2,339 | 2,579 | 3,101 | 3,462 | 3,534 | 3,588 | 3,806 |
| Reference price 2 | 53.41 | 27.86 | 31.99 | 21.17 | 15.45 | 13.71 | 13.71 | 13.71 |
| Nbr of stocks (in thousands) | 87,889 | 120,948 | 125,498 | 126,383 | 128,455 | 129,580 | - | - |
| Announcement Date | 28/02/22 | 01/03/23 | 26/02/24 | 03/03/25 | 02/03/26 | - | - | - |
1USD in Million2USD
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| -94.85x | 1.56x | 9.99x | -.--% | 1.78B | ||
| 34.21x | 3.24x | 14.57x | 1.32% | 19.41B | ||
| 62.63x | 4.95x | 33.49x | 0.28% | 12.53B | ||
| 20.77x | 3.02x | 10.67x | 2.04% | 11.72B | ||
| 16.77x | 1.98x | 9.3x | 0.74% | 10.32B | ||
| 24.07x | 1.93x | 16.11x | 0.15% | 9.87B | ||
| 17.77x | 2.6x | 10.62x | 4.55% | 8.92B | ||
| 68.31x | 8.2x | 35.71x | 0.13% | 7.67B | ||
| 11.9x | 1.01x | 5.8x | 2.1% | 6.32B | ||
| 27.94x | 0.81x | 6.74x | 2.31% | 5.95B | ||
| Average | 18.95x | 2.93x | 15.30x | 1.36% | 9.45B | |
| Weighted average by Cap. | 30.25x | 3.17x | 16.36x | 1.38% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- SGRY Stock
- Valuation Surgery Partners, Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















